These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 2388336

  • 1. A comparison of 2 protocols for living-related renal transplantation in children: donor-specific transfusions versus cyclosporine.
    Leone MR, Alexander SR, Melvin T, Striegel J, Reller K, Norman DJ, Barry JM.
    J Urol; 1990 Sep; 144(3):721-3. PubMed ID: 2388336
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Successful transplantation of cyclosporine-treated haploidentical living-related renal recipients without blood transfusions.
    Flechner SM, Kerman RH, Van Buren C, Kahan BD.
    Transplantation; 1984 Jan; 37(1):73-6. PubMed ID: 6229913
    [Abstract] [Full Text] [Related]

  • 4. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
    Flye MW, Burton K, Mohanakumar T, Brennan D, Keller C, Goss JA, Sicard GA, Anderson CB.
    Transplantation; 1995 Dec 27; 60(12):1395-401. PubMed ID: 8545863
    [Abstract] [Full Text] [Related]

  • 5. Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy.
    Knight RJ, Kerman RH, Welsh M, Golden D, Schoenberg L, Van Buren CT, Lewis RM, Kahan BD.
    Transplantation; 1991 Feb 27; 51(2):355-9. PubMed ID: 1994527
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Multivariate analysis of donor-specific versus random transfusion protocols in haploidentical living-related transplants.
    Reed A, Pirsch J, Armbrust MJ, Burlingham WJ, Knechtle SJ, D'Alessandro AM, Sollinger HW, Lorentzen D, Kalayoglu M, Belzer FO.
    Transplantation; 1991 Feb 27; 51(2):382-4. PubMed ID: 1994532
    [Abstract] [Full Text] [Related]

  • 8. Stored blood--an effective immunosuppressive method for transplantation of kidneys from unrelated donors. An 11-year follow-up.
    Galvão MM, Peixinho ZF, Mendes NF, Sabbaga E.
    Braz J Med Biol Res; 1997 Jun 27; 30(6):727-34. PubMed ID: 9292109
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Are blood transfusions beneficial in the cyclosporine era?
    Potter DE, Portale AA, Melzer JS, Feduska NJ, Garovoy MR, Husing RM, Salvatierra O.
    Pediatr Nephrol; 1991 Jan 27; 5(1):168-72. PubMed ID: 2025530
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of a single pretransplant donor-specific transfusion and cyclosporin A administered 24 to 48 hours before one-haplotype-mismatched living related donor kidney transplant.
    Davies CB, Alexander JW, Cofer BR, First MR, Schroeder TJ.
    Ann Surg; 1992 Jun 27; 215(6):618-25; discussion 626. PubMed ID: 1632683
    [Abstract] [Full Text] [Related]

  • 13. Donor specific transfusions: a five-year experience with alternative protocols.
    Norman DJ, Henell K, Fletcher L, Barry J.
    Transplant Proc; 1987 Feb 27; 19(1 Pt 3):2252-4. PubMed ID: 3274504
    [No Abstract] [Full Text] [Related]

  • 14. Donor-specific blood transfusion in living-related renal transplantation: fourteen-year experience.
    Okazaki H, Sato T, Miura S, Amada N.
    Transplant Proc; 1997 Feb 27; 29(1-2):200-2. PubMed ID: 9122962
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
    Barnhart GR, Goldman MH, Hastillo A, Szentpetery S, Wolfgang T, Thompson J, Mohanakumar T, Katz MR, Rider S, Hanrahan J.
    J Heart Transplant; 1985 Feb 27; 4(4):381-4. PubMed ID: 3916511
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Maintenance immunosuppression therapy and outcome of renal transplantation in North American children--a report of the North American Pediatric Renal Transplant Cooperative Study.
    Tejani A, Stablein D, Fine R, Alexander S.
    Pediatr Nephrol; 1993 Apr 27; 7(2):132-7. PubMed ID: 8476703
    [Abstract] [Full Text] [Related]

  • 19. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
    Casale AS, Reitz BA, Greene PS, Augustine S, Baumgartner WA.
    J Thorac Cardiovasc Surg; 1989 Nov 27; 98(5 Pt 2):951-5. PubMed ID: 2811426
    [Abstract] [Full Text] [Related]

  • 20. Renal transplantation from HLA-haploidentical living-related donors: the effects of donor-specific blood transfusions and different immunosuppressive regimens.
    Sakagami K, Saito S, Shiozaki S, Fujiwara T, Haisa M, Niguma T, Kusaka S, Uda M, Matsuno T, Takasu S.
    Acta Med Okayama; 1992 Feb 27; 46(1):1-5. PubMed ID: 1561899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.